1. Home
  2. ELTX vs AMPY Comparison

ELTX vs AMPY Comparison

Compare ELTX & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$14.77

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Logo Amplify Energy Corp.

AMPY

Amplify Energy Corp.

HOLD

Current Price

$4.33

Market Cap

215.9M

Sector

Energy

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
AMPY
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Oil & Gas Production
Sector
Health Care
Energy
Exchange
Nasdaq
Nasdaq
Market Cap
185.4M
215.9M
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
ELTX
AMPY
Price
$14.77
$4.33
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
126.0K
614.5K
Earning Date
05-12-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
232.26
EPS
N/A
N/A
Revenue
$2,301,000.00
$208,637,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$23.83
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.37
$3.11
52 Week High
$16.00
$6.79

Technical Indicators

Market Signals
Indicator
ELTX
AMPY
Relative Strength Index (RSI) 67.60 33.83
Support Level $9.76 $4.13
Resistance Level N/A $4.92
Average True Range (ATR) 1.30 0.18
MACD 0.35 -0.00
Stochastic Oscillator 79.67 8.40

Price Performance

Historical Comparison
ELTX
AMPY

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About AMPY Amplify Energy Corp.

Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The companies oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.

Share on Social Networks: